Paras Healthcare shares made a positive stock market debut on October 28, 2026, listing at Rs 720 per share on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
The listing price was 3.9% higher than the IPO issue price of Rs 693, giving investors a gain of Rs 27 per share at the opening.
The hospital operator raised Rs 1,450 crore through its initial public offering (IPO), which remained open for subscription from October 21 to October 23.
The issue received an overall subscription of around 2.34 times, with institutional investors accounting for a significant share of demand.
For retail investors who received an allotment of 21 shares, the listing price represented a notional gain of Rs 567 over the issue price.
Actual returns may differ depending on the price at which investors sell their shares and any applicable transaction costs.
Paras Healthcare Shares Listing Price and Gains
The company fixed its IPO price band at Rs 660 to Rs 693 per share and ultimately issued shares at the upper end of the range.
With the stock opening at Rs 720, investors who received shares through the IPO saw an initial listing gain of approximately 3.9%.
The IPO lot size was 21 shares, meaning retail applicants needed Rs 14,553 to apply for one lot at the issue price of Rs 693.
At the listing price of Rs 720, those 21 shares were worth Rs 15,120, representing a difference of Rs 567 before charges and taxes.
A positive listing does not necessarily mean the stock will continue to rise.
Share prices can fluctuate after the opening session as investors assess company performance, valuation, demand and broader market conditions.
 How Investors Responded to the Paras Healthcare IPO
The Rs 1,450-crore public issue comprised a fresh issue of shares worth Rs 500 crore and an offer for sale worth Rs 950 crore.
The fresh issue brings capital into the company, while proceeds from the offer for sale go to the shareholders selling their stakes.
The IPO received overall subscriptions of approximately 2.34 times, according to reports.
Demand varied across investor categories, with qualified institutional buyers showing stronger interest than non-institutional investors.
Retail participation also exceeded the shares reserved for that category.
The listing was stronger than some pre-listing expectations suggested.
However, the grey market premium, often watched by IPO applicants before a stock begins trading, is an unofficial indicator and does not guarantee the actual listing price or future performance.
Paras Healthcare Business and Expansion Plans
Paras Healthcare operates hospitals under the Paras Health brand, providing specialised medical services across North India, Bihar and Jharkhand.
The company had eight hospitals with a combined capacity of 2,211 beds, according to reported information available around the IPO.
Its planned expansion includes a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana.
The company has also outlined plans to use part of its fresh issue proceeds to reduce borrowings, with the remaining funds allocated to general corporate purposes.
Investors evaluating the company beyond its debut should consider its financial performance, debt levels, expansion costs and ability to increase hospital occupancy.
Expansion can create opportunities for revenue growth, but new facilities also require capital and time to reach operational maturity.
What Investors Should Watch After Listing
The opening gain provides a snapshot of initial market demand, rather than a guarantee of continued returns.
Investors should monitor official exchange disclosures, quarterly financial results, debt repayment progress and the company’s expansion plans before making decisions about their holdings.
The Paras Healthcare shares listing at Rs 720 marks the company’s entry into the listed market at a premium to its IPO price.
The next phase will depend on business performance and how investors value its growth prospects relative to its financial risks.
